LAV, Boyu & HongShan Re-up in Gene Therapy Play
09 Aug 2024
US$ 19.00
Lilly Asia Ventures, Boyu Capital, Zoo Capital, HongShan and New Alliance Capital have made a follow-on investment ......
Related Publications
Luminous Ventures, recently rebranded from Lightspeed China Partners, and IDG Capital, have made a follow-on ......
KKR & Co Inc (KKR), will launch a tender offer to privatise Tokyo-listed Forum Engineering Inc (Forum), an ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.